Author:
Wechter W. J.,Leipold D. D.,Quiggle D. D.,McCracken J. D.,Murray E. D.,Loughman B. E.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Reference13 articles.
1. Lotsch, J., Geisslinger, G., Mohammadian, P., et al. (1995). Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects, Brit. J. Clin. Pharmacol. 40, 339–346.
2. McCracken, J. D., Wechter, W. J., Liu, Y., et al. (1996). Antiproliferative effects of the enantiomers of flurbiprofen, J. Clin. Pharmacol. 36 (6), 540–545.
3. MDS Panlabs (1998). Report: Testing LOM-5 R-flurbiprofen in carrageenan-induced rat paw edema, July 9, 1998.
4. Rainsford, K. D. (1985). Newer anti-inflammatory drugs, in: Anti-Inflammatory and Antirheumatic Drugs, Vol. II (7), pp. 138–150. CRC Press, Florida.
5. Riendeau, D., Charleson, S., Cromlish, W., et al. (1997). Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays, Canad. J. Physiol. Pharmacol. 75 (9), 1088–1095.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献